NeoGenomics (NEO) CEO Chris Smith to retire
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
Raymond James Reiterates Market Perform Rating on Neogenomics (NEO) 'in light of the moving parts'
January 10, 2025 1:00 PM ESTRaymond James analyst Andrew Cooper reiterated a Market Perform rating and {REMOVEPT} price target on Neogenomics (NASDAQ: NEO)
The analyst comments "This morning, NeoGenomics announced the retirement of current CEO Chris Smith, naming board member Tony Zook as his successor effective the start of 2Q. The company also reaffirmed its 2024 guidance as part of the release. The retirement is somewhat of a surprise, but comes after a near double move since announcement of Smiths appointment and nearly... More
